Nano, Candido B.
HRN: 24-47-71 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/07/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/07/2024
12/14/2024
IV
500mg
Q8h
Septic Encephalopathy
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes